DANA GREER: Open Payments
NPI 1992210991 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 37 payments from 16 companies in 2025. Trend: 2023 $119 · 2024 $902 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $207 |
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Novo Nordisk Inc | 5 | $101 |
| Lilly USA, LLC | 5 | $94 |
| Amgen Inc. | 3 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $42 |
| Gilead Sciences, Inc. | 2 | $39 |
| Dexcom, Inc. | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: APRETUDE, FARXIGA, Wegovy, MOUNJARO, JARDIANCE, AIRSUPRA, AZMIRO, BREZTRI.
Industry payments across TX — which companies pay providers there.
